ChartRow logo
SNY
$47.47+4.72%
as of close, Nov 4, 2026
☾ AH $47.47 +4.72%
Sanofi ADSStock · Healthcare
PeersGSKBMYPFEGILDAMGNNVS
Share this page

SNY — Sanofi ADS price, chart and key statistics

Technical analysis2
Overlay lines0
Addendum charts0
What would $1,000 invested in SNY be worth today? →
SNY returns: By year · By month · By week · Trailing

Key stats#

Price data

Price
$47.47
YTD price return
-2.04%
YTD total return
+3.39%
Market cap
115.8B
Enterprise value
123.5B
Shares outstanding
2.4B
52W low
$39.07
52W high
$52.68
From 52W high
-9.89%
From 52W low
+21.50%
52W range
62%$39.07–$52.68
Beta
0.35

Volume

Rel volume
1.32×
30D volume
4.1M
30D $ vol
173.5M

Fundamentals

EPS (ttm)
$3.60
FCF (ttm)
8.2B
FCF/share
$3.35
Book value/share
$34.41
ROE
10.59%
ROA
5.96%
Debt / equity
0.20×
Current ratio
1.09

Growth (CAGR, ttm) · 10Y

Net income
+46.23%-0.15%-8.77%+6.19%
FCF
+28.20%-2.71%+6.06%n/a
Shares
-3.46%-1.11%-0.51%-0.79%

Per-share growth (CAGR, ttm) · 10Y

EPS
+50.46%+0.95%-8.34%+7.17%
FCF/share
+32.79%-1.62%+6.59%n/a
Book value/share
+7.91%+2.73%+2.09%+3.63%
Dividend/share
+9.07%+8.18%+4.31%+3.44%
Price
-3.34%+1.20%-1.73%+1.85%
Total return
+2.03%+5.99%+2.60%+6.11%

Fundamentals end at the last reported quarter; price and total return end at the latest close.

Valuation

P/E (ttm)
13.2×
P/OI (ttm)
16.1×
Fwd P/E
8.8×
P/B (mrq)
1.4×
P/FCF (ttm)
14.2×
EV/EBITDA (fy)
17.2×
FCF yield (ttm)
7.05%
Dividend yield (fwd)Div yield
5.10%
Dividend yield (ttm)
5.10%
Dividend/share (fwd)
$2.42
Buyback yield (realized, 1y)
3.46%
Shareholder yield (realized, 1y)
7.89%
Buyback yield (cash, ttm)
4.73%
Shareholder yield (cash, ttm)
9.39%

Vs own 10Y history

P/E
28th
P/OI
56th
P/B
9th
P/FCF
31st

Bar = where today’s multiple sits in SNY’s own 10-year range:near a decade-low (cheap)→mid-range→near a decade-high (rich).

Performance · price returntotal return · as of 2026-11-04#

1D
+4.72%
5D
+12.38%
1M
+18.91%
3M
+11.22%
YTD
-2.04%
1Y
-3.34%
5Y
-8.34%
1D
+4.72%
5D
+12.38%
1M
+18.91%
3M
+11.22%
YTD
+3.39%
1Y
+2.02%
5Y
+13.68%

Fundamentals#

Net income

5Y CAGR −8.8%10Y CAGR +6.2%
$8.9B FY25
FY15FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25

No quarters filed for this figure.

Operating income

5Y CAGR −14.9%5Y CAGR −14.9%
$7.2B FY25
FY17FY18FY19FY20FY21FY22FY23FY24FY25

No quarters filed for this figure.

EPS (diluted)

5Y CAGR −8.3%10Y CAGR +7.2%
$3.60 FY25
FY15FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25

No quarters filed for this figure.

Free cash flow

5Y CAGR +6.1%5Y CAGR +6.1%
$8.2B FY25
FY19FY20FY21FY22FY23FY24FY25

FY25: operating cash flow $12.2B, capex −$4B

No quarters filed for this figure.

Shares (diluted)

5Y −2.7%10Y −7.2%
2.5B FY25
FY15FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25

No quarters filed for this figure.

Dividend per share

5Y CAGR +4.3%10Y CAGR +3.4%
$2.22 FY25
FY15FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25

No quarters filed for this figure.

Full SNY financials →

About Sanofi ADS#

Sanofi ADR is an American Depositary Receipt representing shares of Sanofi, a global healthcare company focused on pharmaceuticals and vaccines. Through its ADR program, U.S. investors can access the company’s ordinary shares in a form that is traded in the United States, while the underlying business remains centered in France. Sanofi develops, manufactures, and commercializes prescription medicines across several therapeutic areas, including specialty care, general medicines, and immunology, and it also operates a major vaccines business. The company serves patients, healthcare providers, and public health systems in markets around the world, with products used in chronic, rare, and infectious diseases. Sanofi ADR reflects the company’s broad role in the global biopharmaceutical market, combining research, production, and distribution capabilities with a diversified healthcare portfolio.

Paris, France·74,846 employees·Drug Manufacturers - General·sanofi.com·As of Oct 28, 2026

Recent filings#

No earnings release, press release or insider trade outside a 10b5-1 plan in the last 120 days.

All filings and insider trades →
TickerName1M1D
LLYEli Lilly and Company+24.07%+0.61%
JNJJohnson & Johnson+7.92%+3.81%
ABBVAbbVie Inc.+12.18%+3.09%
MRKMerck & Co. Inc.+4.20%+3.93%
UNHUnitedHealth Group Incorporated Common Stock (DE)+10.08%+1.22%
NVSNovartis AG+17.01%+3.59%
TMOThermo Fisher Scientific Inc.+7.84%+1.12%
AMGNAmgen Inc.+18.69%+3.71%